Intro

Easy 20–30 Minute Procedure

A quick, typically painless same-day surgery that can help you achieve better vision.

Pre-Op Eye Exam

Before you schedule your EVO ICL lens (EVO) procedure your doctor will perform a series of standard tests to measure your eye’s unique characteristics for the procedure. Once your doctor determines that EVO ICL is a good option for you, they will educate you about the procedure and what to expect both during and after the procedure.

Getting Your EVO ICLs

When you arrive for your procedure your doctor will administer eye drops to dilate your pupils as well as anesthetize your eyes.

Returning Home

At this point, the procedure is over and many patients will have improved vision nearly immediately. Your doctor will prescribe more eye drops intended to aid in the healing process following the procedure. You will need someone to drive you home, your doctor will tell you when your vision allows driving. See why the EVO lens is worth the wait. Click here to watch the video.

Real Life Stories From Real Life Patients

My vision is not only the sharpest it has ever been in my life... it's the fact that everywhere I look, my vision is just super crisp... I just see so much better than I've ever seen before.

Dr. Joseph J. Allen, Optometrist

I feel like a big part of health is using what your body already has. Visian ICL is in line with that because it’s keeping your eye completely intact. My eye is still my eye.

Eve Torres Gracie, Jiu Jitsu Instructor

I had my first opportunity to put my Visian ICL eyes to the test recently in the Amazon rainforest, and it couldn’t have been more exciting to be able to spot rare species better than ever.

Phil Torres, Entomologist, TV show host

The thing that I love about the Visian ICL is that they are putting a lens in there that can be removed.

Jennifer Puno, Web Designer

There’s a few big road blocks to having glasses and being a photographer. Now I’ve got EVO and I can run out and live my life unhindered.

Andrew Oxenham, Photographer

I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmer's market.

Sara Tso, Chef

What is EVO ICL?

The High-Tech Vision Correction Procedure

How does the EVO ICL Work?

Learn about the implantable lens

What are the benefits?

Treat nearsightedness with the EVO ICL vision procedure

What is the difference between EVO ICL and LASIK?

Know your vision solutions

EVO ICL is FDA Approved!

Understanding the approval process

Important Safety Information

The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.

Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.

You should NOT have EVO Visian ICL surgery if:

  • Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL
  • You are pregnant or nursing
  • You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma)
  • You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor
  • Your vision is not stable as determined by your eye doctor

Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.

References

References

1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.

2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.

3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.

4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.

5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul; 262(7):2321-2328

6. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. Eur J of Ophthalmol. 2007; 17(1): pp. 1-6.

7. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg., Volume 26 , Issue 9 , 1326 - 1331.

8. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

9. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.

*American Refractive Surgery Council